COREVALVE REVALVING SYSTEM
Report
- Report Number
- 2025587-2017-00980
- Event Type
- Injury
- Date Received
- June 16, 2017
- Date of Event
- August 18, 2015
- Report Date
- June 2, 2017
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- NPT
- PMA / PMN Number
- P130021
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
Narratives
CITATION: M. ABDEL-WAHAB ET AL. "1-YEAR OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT WITH BALLOON-EXPANDABLE VERSUS SELF-EXPANDABLE VALVES RESULTS FROM THE CHOICE RANDOMIZED CLINICAL TRIAL" J AM COLL CARDIOL 2015;66:791¿800. HTTP://DX.DOI.ORG/10.1016/J.JACC.2015.06.026 EARLIEST DATE OF PUBLISH USED FOR EVENT DATE . NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. (B)(4).
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING 1-YEAR OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT WITH BALLOON-EXPANDABLE VERSUS SELF-EXPANDABLE VALVES. ALL DATA WERE COLLECTED FROM MULTIPLE CENTERS. THE STUDY POPULATION INCLUDED 241 PATIENTS, PREDOMINATELY FEMALE, MEAN AGE 82 YEARS), OF WHICH 120 WERE IMPLANTED WITH A MEDTRONIC COREVALVE (SERIAL NUMBERS NOT PROVIDED). OVERALL DURING THE STUDY, FIFTEEN DEATHS (ELEVEN WERE CARDIOVASCULAR) WERE REPORTED IN THE SELF-EXPANDABLE VALVE GROUP, HOWEVER BASED ON THE AVAILABLE INFORMATION, NONE OF THE DEATHS WERE ATTRIBUTED TO A MEDTRONIC PRODUCT. AMONG ALL PATIENTS ADVERSE EVENTS INCLUDED: STROKE, MI, HEART FAILURE, BLEEDING, ENDOCARDITIS, VALVE DYSFUNCTION, ATRIAL FIBRILLATION, PACEMAKER IMPLANT, BASED ON THE AVAILABLE INFORMATION, THESE EVENTS MAY HAVE BEEN ATTRIBUTED TO MEDTRONIC PRODUCT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 427899 | COREVALVE REVALVING SYSTEM | AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED | NPT | MEDTRONIC HEART VALVES DIVISION | CRS |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 82 YR | Life Threatening| R |